Recall: D-247-2013

Class II - Potentially Harmful

Class IIClassification

2013-02-26Initiated

TerminatedStatus

Teva Pharmaceuticals USA, Inc.Firm

Product

Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.

Reason

Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.